Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Neven

Showing results (81-90 of 383) with videos related to

Pageof 39
Sort By:
Translational Oncology|October 11, 2022
Impact of baseline telomere length on survival and chemotherapy related toxicity in breast cancer patients receiving (neo)adjuvant anthracycline containing chemotherapySigrid Hatse, Marta Serena, Christof Vulsteke, et al.
Cancer Treatment Reviews|January 11, 2015
A new era of improving progression-free survival with dual blockade in postmenopausal HR(+), HER2(-) advanced breast cancerGuy Jerusalem, Thomas Bachelot, Carlos Barrios, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2012
Need for estradiol assays with a lower functional sensitivity in clinical studies examining postmenopausal women treated with aromatase inhibitorsSteven Pauwels, Anneleen Lintermans, Patrick Neven, et al.
Cancers|November 13, 2020
Therapeutic Strategies for the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive (HR+/HER2+) Breast Cancer: A Review of the Current LiteratureEirini Thanopoulou, Leila Khader, Morena Caira, et al.
Gynecologic Oncology|October 16, 2012
The "Leuven" paclitaxel/carboplatin weekly regimen in patients with recurrent ovarian cancer, a retrospective studyIsabelle Cadron, Leyla Abdulkadir, Evelyn Despierre, et al.
Breast Cancer : Basic and Clinical Research|February 10, 2025
Plasma Iron Levels at Early Breast Cancer Diagnosis Are Associated With Development of Secondary Metastases: A Single-Center Retrospective Cohort StudyJasmine De Troy, Sarah-Maria Fendt, Sigrid Hatse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2019
Reply to C.L. Braal et al, H. Brauch et al, and M.P. Goetz et alHenk-Jan Guchelaar, Anabel Sanchez-Spitman, Vincent Dezentjé, et al.
Archives of Public Health = Archives Belges De Sante Publique|May 7, 2024
Breast cancer incidence, stage distribution, and treatment shifts during the 2020 COVID-19 pandemic: a nationwide population-level studyHanna M Peacock, Lien van Walle, Geert Silversmit, et al.
Gynecologic Oncology|June 19, 2012
Treatment of high-risk gestational trophoblastic neoplasia with weekly high-dose methotrexate-etoposideSileny N Han, Frédéric Amant, Karin Leunen, et al.
Archives of Physical Medicine and Rehabilitation|January 18, 2015
Effectiveness of postoperative physical therapy for upper-limb impairments after breast cancer treatment: a systematic reviewAn De Groef, Marijke Van Kampen, Evi Dieltjens, et al.
Pageof 39

Showing results (81-90 of 383) with videos related to

Sort By:
Pageof 39
Translational Oncology|October 11, 2022
Impact of baseline telomere length on survival and chemotherapy related toxicity in breast cancer patients receiving (neo)adjuvant anthracycline containing chemotherapySigrid Hatse, Marta Serena, Christof Vulsteke, et al.
Cancer Treatment Reviews|January 11, 2015
A new era of improving progression-free survival with dual blockade in postmenopausal HR(+), HER2(-) advanced breast cancerGuy Jerusalem, Thomas Bachelot, Carlos Barrios, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2012
Need for estradiol assays with a lower functional sensitivity in clinical studies examining postmenopausal women treated with aromatase inhibitorsSteven Pauwels, Anneleen Lintermans, Patrick Neven, et al.
Cancers|November 13, 2020
Therapeutic Strategies for the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive (HR+/HER2+) Breast Cancer: A Review of the Current LiteratureEirini Thanopoulou, Leila Khader, Morena Caira, et al.
Gynecologic Oncology|October 16, 2012
The "Leuven" paclitaxel/carboplatin weekly regimen in patients with recurrent ovarian cancer, a retrospective studyIsabelle Cadron, Leyla Abdulkadir, Evelyn Despierre, et al.
Breast Cancer : Basic and Clinical Research|February 10, 2025
Plasma Iron Levels at Early Breast Cancer Diagnosis Are Associated With Development of Secondary Metastases: A Single-Center Retrospective Cohort StudyJasmine De Troy, Sarah-Maria Fendt, Sigrid Hatse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2019
Reply to C.L. Braal et al, H. Brauch et al, and M.P. Goetz et alHenk-Jan Guchelaar, Anabel Sanchez-Spitman, Vincent Dezentjé, et al.
Archives of Public Health = Archives Belges De Sante Publique|May 7, 2024
Breast cancer incidence, stage distribution, and treatment shifts during the 2020 COVID-19 pandemic: a nationwide population-level studyHanna M Peacock, Lien van Walle, Geert Silversmit, et al.
Gynecologic Oncology|June 19, 2012
Treatment of high-risk gestational trophoblastic neoplasia with weekly high-dose methotrexate-etoposideSileny N Han, Frédéric Amant, Karin Leunen, et al.
Archives of Physical Medicine and Rehabilitation|January 18, 2015
Effectiveness of postoperative physical therapy for upper-limb impairments after breast cancer treatment: a systematic reviewAn De Groef, Marijke Van Kampen, Evi Dieltjens, et al.
Pageof 39